We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Immune Thrombocytopenia After α-Interferon Therapy in Patients With Cancer

E. A. Abdi, MB, BS; P. M. Venner, MD
JAMA. 1986;255(14):1878-1879. doi:10.1001/jama.1986.03370140076016.
Text Size: A A A
Published online


To the Editor.—  The recent report by McLaughlin et al1 deserves some comments. Criteria considered in making a diagnosis of drug-induced immune thrombocytopenia include the following: (1) a consistent clinical history of exposure to drug, (2) exclusion of all other causes, (3) recurrence of thrombocytopenia after rechallenge with the drug, and (4) a positive in vitro test showing a specific drug-dependent effect on platelets.2 This report fails to satisfy several of these criteria. First, other causes have not been excluded. We are not given any information about other drugs given concurrently. Almost all patients receiving interferon require an antipyretic agent and many also require antiemetics. The possibility of other drugs causing immune thrombocytopenia has not therefore been excluded.We are not informed if any of these patients had antecedent viral or bacterial infection that may have caused immune thrombocytopenia. After rechallenge with interferon, thrombocytopenia should occur again, which


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.